In-Vitro毒性試験の世界市場レポート 2025年

In-Vitro毒性試験の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR10.7％で191億8,000万米ドルに成長します。予測期間の成長は、個別化医療への注力、予測毒性モデルの需要、環境試験の拡大、がん領域の医薬品開発課題、内分泌攪乱物質スクリーニングへの注力、多臓器チップへのシフトなどに起因すると考えられます。予測期間における主な動向としては、3d細胞培養技術の進歩、ハイスループットスクリーニングの統合、臓器オンチップ技術への注目、化学物質安全性評価への応用、ヒト由来細胞株の使用、オミックス技術の取り込み、教育イニシアティブやトレーニングプログラムなどが挙げられます。

ヘルスケア支出の増加は、In-Vitro毒性試験市場の成長を促進すると予想されます。ヘルスケア支出とは、病院、在宅医療サービス、処方薬、介護施設、個人的なヘルスケアなどのサービスに個人や政府が支出する総額のことです。この支出は、In-Vitro毒性試験を必要とする疾病の有病率の増加により、世界的に増加しています。例えば、米国連邦政府機関であるメディケア・メディケイド・サービスセンターが発表した報告書によると、2023年から2032年までの国民医療費（NHE）の平均成長率は5.6％となり、GDPの平均成長率4.3％を上回ると予測しています。その結果、GDPに占める医療費の割合は、2022年の17.3％から2032年には19.7％に上昇すると予想されます。したがって、ヘルスケア支出の増加がIn-Vitro毒性試験市場の成長を牽引しています。

In-Vitro毒性試験市場は、製薬業界の拡大により、さらに活性化することが予想されます。医薬品の研究開発、生産、市場開拓を担うこの分野では、In-Vitro毒性試験サービスに対する需要が増加しています。これらのサービスは、新薬候補のスクリーニングや既存製品の安全性確保において重要な役割を果たしています。Atradiusの2022年3月のレポートによると、米国の医薬品市場は世界市場の約45%を占め、世界の生産量の22%に貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のIn-Vitro毒性試験PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のIn-Vitro毒性試験市場：成長率分析
• 世界のIn-Vitro毒性試験市場の実績：規模と成長, 2019-2024
• 世界のIn-Vitro毒性試験市場の予測：規模と成長, 2024-2029, 2034F
• 世界のIn-Vitro毒性試験総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のIn-Vitro毒性試験市場：製品とサービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 消耗品
• アッセイ
• 装置
• ソフトウェア
• サービス
• 世界のIn-Vitro毒性試験市場：方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞アッセイ
• 生化学アッセイ
• In Silicoモデル
• 生体外モデル
• 世界のIn-Vitro毒性試験市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞培養技術
• ハイスループット技術
• 毒性ゲノミクス
• 世界のIn-Vitro毒性試験市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経毒性
• 経皮毒性
• 細胞毒性
• その他の用途
• 世界のIn-Vitro毒性試験市場：業界別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品およびバイオ医薬品
• 化粧品および家庭用品
• 食品
• 化学薬品
• 世界のIn-Vitro毒性試験市場：消耗品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬
• 細胞培養培地
• プレートとバイアル
• 世界のIn-Vitro毒性試験市場：アッセイのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞ベースのアッセイ
• 生化学アッセイ
• 遺伝毒性試験
• 世界のIn-Vitro毒性試験市場：機器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動化システム
• 顕微鏡
• プレートリーダー
• 世界のIn-Vitro毒性試験市場：ソフトウェアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ分析ソフトウェア
• 検査情報管理システム（LIMS）
• 毒性モデリングソフトウェア
• 世界のIn-Vitro毒性試験市場：サービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• テストサービス
• コンサルティングサービス
• 規制コンプライアンスサービス

第7章 地域別・国別分析

• 世界のIn-Vitro毒性試験市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のIn-Vitro毒性試験市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• In-Vitro毒性試験市場：競合情勢
• In-Vitro毒性試験市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings（LabCorp）Overview, Products and Services, Strategy and Financial Analysis
  • Gentronix Limited（a subsidiary of Eurofins Scientific SE）Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Eurofins Scientific SE
• Charles River Laboratories International Inc.
• Promega Corporation
• Agilent Technologies Inc.
• Evotec SE
• SGS SA
• BioIVT LLC
• MB Research Laboratories LLC
• Creative Biolabs Inc.
• Creative Bioarray Inc.
• InSphero AG
• PerkinElmer Inc.
• Cyprotex PLC
• MatTek Corporation
• Danaher Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• In-Vitro毒性試験市場2029：新たな機会を提供する国
• In-Vitro毒性試験市場2029：新たな機会を提供するセグメント
• In-Vitro毒性試験市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

In-vitro toxicology testing encompasses a range of assays and tests utilized to determine toxic dosages of substances like drugs, nutraceuticals, and food additives, identifying their potential toxicity upon administration. Its primary goal is to detect the presence of harmful chemicals and residual solvents, effectively reducing exposure to hazardous elements. This form of testing is predominantly employed in assessing medication doses that demonstrate toxicity during preclinical development, drug discovery, and development stages.

The core products within in-vitro toxicology testing comprise consumables, assays, equipment, software, and services. Consumables encompass various products utilized in laboratory testing procedures, including items like cannulas and lancets for compound analysis. The methods employed consist of cellular assays, biochemical assays, in silico models, and ex vivo models, employing technologies such as cell culture and high-throughput methodologies. These techniques are applied across various applications, encompassing neurotoxicity, dermal toxicity, cytotoxicity, and other related domains. The industry verticals served include pharmaceuticals, biopharmaceuticals, cosmetics, household products, food, and chemicals.

The in-vitro toxicology testing market research report is one of a series of new reports from The Business Research Company that provides in-vitro toxicology testing market statistics, including in-vitro toxicology testing industry global market size, regional shares, competitors with an in-vitro toxicology testing market share, detailed in-vitro toxicology testing market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro toxicology testing industry. This in-vitro toxicology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro toxicology testing market size has grown rapidly in recent years. It will grow from $11.53 billion in 2024 to $12.77 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to regulatory requirements, ethical concerns and animal welfare, cost and time efficiency, globalization of the pharmaceutical industry, drug discovery and development demands, public awareness of environmental toxins.

The in-vitro toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $19.18 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to focus on personalized medicine, demand for predictive toxicology models, expansion of environmental testing, oncology drug development challenges, focus on endocrine disruptor screening, shift towards multi-organ chips. Major trends in the forecast period include advancements in 3d cell culture technologies, integration of high-throughput screening, focus on organ-on-a-chip technologies, application in chemical safety assessment, use of human-derived cell lines, incorporation of omics technologies, educational initiatives and training programs.

The increasing healthcare expenditure is anticipated to drive growth in the in-vitro toxicology testing market. Healthcare expenditure refers to the total amount of money spent by individuals and the government on services such as hospitals, home health services, prescription medications, nursing facilities, and personal healthcare. This spending is rising globally due to the increasing prevalence of diseases that necessitate in-vitro toxicology testing. For example, a report published by the Centers for Medicare & Medicaid Services, a U.S. federal agency, projects that from 2023 to 2032, the average growth rate of national health expenditure (NHE) will be 5.6%, exceeding the average GDP growth rate of 4.3%. Consequently, the proportion of health spending relative to GDP is expected to rise from 17.3% in 2022 to 19.7% by 2032. Therefore, the rising healthcare expenditure is driving the growth of the in-vitro toxicology testing market.

The in-vitro toxicology testing market is set to experience a boost owing to the expanding pharmaceutical industry. This sector, responsible for researching, developing, producing, and marketing pharmaceutical drugs, is witnessing an increased demand for in-vitro toxicology testing services. These services play a critical role in screening new drug candidates and ensuring the safety of existing products. A March 2022 report by Atradius revealed that the US pharmaceutical market represents roughly 45% of the global market and contributes to 22% of the world's production, signifying significant growth potential in driving the demand for in-vitro toxicology testing within this industry.

The rise of innovative cell therapies is a prominent trend gaining momentum in the in-vitro toxicology market. Key players in the in-vitro toxicology testing industry are focusing on developing new funding solutions to strengthen their competitive edge. For instance, in June 2024, Waypoint Bio, a biotechnology company based in the U.S., announced that it had secured $14.5 million in seed funding for its novel cell therapies aimed at solid tumors, employing in vivo spatial pooled screening technology. This platform uniquely integrates spatial biology with pooled screening, allowing for the simultaneous examination of how various cell therapy candidates interact with the solid tumor microenvironment. The system evaluates hundreds of phenotypes at the single-cell level, providing researchers with valuable insights into not only which therapies prove effective but also the reasons behind their successes or failures based on interactions within the tumor environment.

Leading companies in the in-vitro toxicology testing market are pursuing strategic partnerships to enhance their capabilities in providing inhalation toxicology tests and strengthen their market positions. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefit and success. For example, in November 2024, Charles River Laboratories International Inc., a U.S.-based provider of pharmaceutical products and services, partnered with Met Tak Life Sciences, a U.S.-based biotechnology firm, to develop a novel approach methodology (NAM) inhalation toxicology test aimed at reducing dependence on traditional animal research methods. By integrating MatTek's advanced 3D human tissue models into their toxicology testing workflows, the collaboration seeks to bridge the gap between animal testing and human biology.

In January 2022, Inotiv Inc., a U.S.-based contract research organization, acquired Integrated Laboratory Systems, LLC for $56 million. This acquisition is set to enhance Inotiv's expertise in computational and in vitro methods for predictive toxicology assessments. Integrated Laboratory Systems, LLC, also based in the U.S., specializes in providing in vivo and in vitro toxicology services.

Major companies operating in the in-vitro toxicology testing market are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation

North America was the largest region in the in- vitro toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in-vitro toxicology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in-vitro toxicology testing market includes revenues earned by entities by providing metabolic, toxicokinetic, and bioanalytical investigations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Toxicology Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro toxicology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro toxicology testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in-vitro toxicology testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Consumables; Assays; Equipment; Software; Services
• 2) By Method: Cellular Assays; Biochemical Assays; In Silico Models; Ex Vivo Models
• 3) By Technology: Cell Culture Technologies; High-throughput Technologies; Toxicogenomics
• 4) By Applications: Neurotoxicity; Dermal toxicity; Cytotoxicity; Other Applications
• 5) By Industry: Pharmaceuticals And Biopharmaceuticals; Cosmetic And Household Products; Food; Chemicals
• Subsegments:
• 1) By Consumables: Reagents; Cell Culture Media; Plates And Vials
• 2) By Assays: Cell-Based Assays; Biochemical Assays; Genetic Toxicity Assays
• 3) By Equipment: Automated Systems; Microscopes; Plate Readers
• 4) By Software: Data Analysis Software; Laboratory Information Management Systems (LIMS); Toxicology Modeling Software
• 5) By Services: Testing Services; Consultation Services; Regulatory Compliance Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Laboratory Corporation of America Holdings (LabCorp); Gentronix Limited (a subsidiary of Eurofins Scientific SE); Bio-Rad Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In-Vitro Toxicology Testing Market Characteristics

3. In-Vitro Toxicology Testing Market Trends And Strategies

4. In-Vitro Toxicology Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global In-Vitro Toxicology Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global In-Vitro Toxicology Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global In-Vitro Toxicology Testing Market Growth Rate Analysis
• 5.4. Global In-Vitro Toxicology Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global In-Vitro Toxicology Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global In-Vitro Toxicology Testing Total Addressable Market (TAM)

6. In-Vitro Toxicology Testing Market Segmentation

• 6.1. Global In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Assays
• Equipment
• Software
• Services
• 6.2. Global In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cellular Assays
• Biochemical Assays
• In Silico Models
• Ex Vivo Models
• 6.3. Global In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Culture Technologies
• High-throughput Technologies
• Toxicogenomics
• 6.4. Global In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neurotoxicity
• Dermal Toxicity
• Cytotoxicity
• Other Applications
• 6.5. Global In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceuticals And Biopharmaceuticals
• Cosmetic And Household Products
• Food
• Chemicals
• 6.6. Global In-Vitro Toxicology Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents
• Cell Culture Media
• Plates And Vials
• 6.7. Global In-Vitro Toxicology Testing Market, Sub-Segmentation Of Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell-Based Assays
• Biochemical Assays
• Genetic Toxicity Assays
• 6.8. Global In-Vitro Toxicology Testing Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Systems
• Microscopes
• Plate Readers
• 6.9. Global In-Vitro Toxicology Testing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Software
• Laboratory Information Management Systems (LIMS)
• Toxicology Modeling Software
• 6.10. Global In-Vitro Toxicology Testing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Testing Services
• Consultation Services
• Regulatory Compliance Services

7. In-Vitro Toxicology Testing Market Regional And Country Analysis

• 7.1. Global In-Vitro Toxicology Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global In-Vitro Toxicology Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In-Vitro Toxicology Testing Market

• 8.1. Asia-Pacific In-Vitro Toxicology Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In-Vitro Toxicology Testing Market

• 9.1. China In-Vitro Toxicology Testing Market Overview
• 9.2. China In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In-Vitro Toxicology Testing Market

• 10.1. India In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In-Vitro Toxicology Testing Market

• 11.1. Japan In-Vitro Toxicology Testing Market Overview
• 11.2. Japan In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In-Vitro Toxicology Testing Market

• 12.1. Australia In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In-Vitro Toxicology Testing Market

• 13.1. Indonesia In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In-Vitro Toxicology Testing Market

• 14.1. South Korea In-Vitro Toxicology Testing Market Overview
• 14.2. South Korea In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In-Vitro Toxicology Testing Market

• 15.1. Western Europe In-Vitro Toxicology Testing Market Overview
• 15.2. Western Europe In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In-Vitro Toxicology Testing Market

• 16.1. UK In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In-Vitro Toxicology Testing Market

• 17.1. Germany In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In-Vitro Toxicology Testing Market

• 18.1. France In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In-Vitro Toxicology Testing Market

• 19.1. Italy In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In-Vitro Toxicology Testing Market

• 20.1. Spain In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In-Vitro Toxicology Testing Market

• 21.1. Eastern Europe In-Vitro Toxicology Testing Market Overview
• 21.2. Eastern Europe In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In-Vitro Toxicology Testing Market

• 22.1. Russia In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In-Vitro Toxicology Testing Market

• 23.1. North America In-Vitro Toxicology Testing Market Overview
• 23.2. North America In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In-Vitro Toxicology Testing Market

• 24.1. USA In-Vitro Toxicology Testing Market Overview
• 24.2. USA In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In-Vitro Toxicology Testing Market

• 25.1. Canada In-Vitro Toxicology Testing Market Overview
• 25.2. Canada In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In-Vitro Toxicology Testing Market

• 26.1. South America In-Vitro Toxicology Testing Market Overview
• 26.2. South America In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In-Vitro Toxicology Testing Market

• 27.1. Brazil In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In-Vitro Toxicology Testing Market

• 28.1. Middle East In-Vitro Toxicology Testing Market Overview
• 28.2. Middle East In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In-Vitro Toxicology Testing Market

• 29.1. Africa In-Vitro Toxicology Testing Market Overview
• 29.2. Africa In-Vitro Toxicology Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa In-Vitro Toxicology Testing Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In-Vitro Toxicology Testing Market Competitive Landscape And Company Profiles

• 30.1. In-Vitro Toxicology Testing Market Competitive Landscape
• 30.2. In-Vitro Toxicology Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Gentronix Limited (a subsidiary of Eurofins Scientific SE) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. In-Vitro Toxicology Testing Market Other Major And Innovative Companies

• 31.1. Eurofins Scientific SE
• 31.2. Charles River Laboratories International Inc.
• 31.3. Promega Corporation
• 31.4. Agilent Technologies Inc.
• 31.5. Evotec SE
• 31.6. SGS SA
• 31.7. BioIVT LLC
• 31.8. MB Research Laboratories LLC
• 31.9. Creative Biolabs Inc.
• 31.10. Creative Bioarray Inc.
• 31.11. InSphero AG
• 31.12. PerkinElmer Inc.
• 31.13. Cyprotex PLC
• 31.14. MatTek Corporation
• 31.15. Danaher Corporation

32. Global In-Vitro Toxicology Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In-Vitro Toxicology Testing Market

34. Recent Developments In The In-Vitro Toxicology Testing Market

35. In-Vitro Toxicology Testing Market High Potential Countries, Segments and Strategies

• 35.1 In-Vitro Toxicology Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 In-Vitro Toxicology Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 In-Vitro Toxicology Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer